By Jim Stafford Copyright © 2017, The Oklahoma Publishing Co. Seated next to each other on a stage Tuesday morning at the Oklahoma Medical Research Foundation were the alpha and omega of Oklahoma City’s Selexys Pharmaceuticals. Dr. Rodger P. McEver and Russell Rother shared the stage as part of a panel discussion on “Relationship DynamicsRead more
News
Dr. Russell Rother’s plan to return to Oklahoma in the 1990s to work in academia was sidetracked by his success in helping build Connecticut-based Alexion Pharmaceuticals into a $26 billion company.
Oklahoma City-based Selexys Pharmaceuticals Corp. is enrolling patients in a Phase 2 trial of a drug designed to treat sickle cell disease.
